Momen Gele is a topical analgesic and anti-inflammatory drug containing benzydamine.
This agent was discovered in 1964 by the Angelini research laboratories. So far, it is an international drug containing a molecule that was discovered and patented by the Italian company Angelini. Benzydamine is marketed directly by Angelini in Italy, Spain and Portugal. It is also marketed in many other countries through a worldwide network of licensees.
Benzydamine is an anti-inflammatory drug belonging to the class of NSAIDs (NonSteroidal Anti-Inflammatory Drugs). This acronym refers to the drugs which do not contain cortisone and are active in fighting pain and inflammation. Due to its specific mechanism of action, benzydamine inhibits the synthesis of prostaglandins, the substances involved in the inflammatory process, and increases the resistance of the body cells to pathogens. Moreover, benzydamine has local disinfectant and anaesthetic properties and is also well tolerated.